uniQure (QURE) Amortizatization of Intangibles (2023 - 2026)
uniQure (QURE) recorded quarterly Amortizatization of Intangibles of -$4.3 million in Q1 2026, up 0.85% quarter-over-quarter from -$4.4 million in Q4 2025, and down 104.77% on a YoY basis from $90.9 million in Q1 2025.
uniQure (QURE) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
uniQure's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 104.77% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$12.7 million (down 36.02% YoY), while the FY2025 annual figure was -$10.5 million, up 4.02% from the prior year.
- Amortizatization of Intangibles was -$4.3 million for Q1 2026 at uniQure, up from -$4.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of -$912000.0 in Q2 2023 to a low of -$4.7 million in Q3 2023.
- Historically, Amortizatization of Intangibles has averaged -$2.8 million across 4 years, with a median of -$2.4 million in 2024.
- Biggest YoY gain for Amortizatization of Intangibles was 61.64% in 2024; the steepest drop was 299.46% in 2024.
- A 4-year view of Amortizatization of Intangibles shows it stood at -$4.4 million in 2023, then soared by 44.64% to -$2.4 million in 2024, then slumped by 79.99% to -$4.4 million in 2025, then grew by 0.85% to -$4.3 million in 2026.
- The last three Amortizatization of Intangibles figures came in at -$4.3 million (Q1 2026), -$4.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.34 Mn |
| Mar 31, 2026 | -4.34 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | -4.39 Mn |
| Dec 31, 2023 | -4.39 Mn |